Avantor, Inc. (NYSE:AVTR) Given Average Rating of “Moderate Buy” by Analysts

Shares of Avantor, Inc. (NYSE:AVTR) have been given an average recommendation of “Moderate Buy” by the thirteen brokerages that are presently covering the firm, MarketBeat reports. Two equities research analysts have rated the stock with a hold recommendation and eleven have issued a buy recommendation on the company. The average twelve-month target price among analysts that have issued ratings on the stock in the last year is $27.69.

AVTR has been the topic of several recent analyst reports. Royal Bank of Canada restated an “outperform” rating and set a $34.00 price objective on shares of Avantor in a research report on Thursday, September 26th. UBS Group lowered their price objective on Avantor from $30.00 to $29.00 and set a “buy” rating on the stock in a research report on Tuesday, October 8th. Robert W. Baird cut their target price on Avantor from $27.00 to $26.00 and set an “outperform” rating for the company in a research report on Monday, October 28th. Wells Fargo & Company lowered their price target on Avantor from $30.00 to $28.00 and set an “overweight” rating on the stock in a report on Monday, October 28th. Finally, Barclays cut their price objective on shares of Avantor from $28.00 to $25.00 and set an “overweight” rating for the company in a report on Friday, October 25th.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in AVTR. Bank of New York Mellon Corp lifted its stake in shares of Avantor by 1.6% in the 2nd quarter. Bank of New York Mellon Corp now owns 2,325,329 shares of the company’s stock valued at $49,297,000 after purchasing an additional 35,497 shares during the last quarter. Allspring Global Investments Holdings LLC boosted its stake in Avantor by 35.1% during the second quarter. Allspring Global Investments Holdings LLC now owns 1,157,855 shares of the company’s stock worth $24,547,000 after buying an additional 300,579 shares during the period. Cambridge Investment Research Advisors Inc. bought a new position in Avantor during the second quarter valued at $2,353,000. Kintegral Advisory LLC bought a new position in Avantor during the second quarter valued at $514,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank lifted its holdings in shares of Avantor by 2.0% in the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 359,580 shares of the company’s stock worth $7,623,000 after acquiring an additional 7,156 shares during the last quarter. Hedge funds and other institutional investors own 95.08% of the company’s stock.

Avantor Trading Up 0.5 %

Avantor stock opened at $21.36 on Thursday. The company has a current ratio of 1.54, a quick ratio of 1.06 and a debt-to-equity ratio of 0.84. Avantor has a 12-month low of $19.59 and a 12-month high of $28.00. The firm has a market capitalization of $14.54 billion, a price-to-earnings ratio of 46.43, a P/E/G ratio of 2.75 and a beta of 1.29. The firm has a 50 day moving average of $22.00 and a 200 day moving average of $23.40.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.